Alpha-tocotrienol is the most abundant tocotrienol isomer circulated in plasma and lipoproteins after postprandial tocotrienol-rich vitamin E supplementation

Nutrition Journal

Kalyana Sundram¹  Hwee M Cheng²  Rosnah M Nor³  Syed Fairus³ 

[1] Malaysian Palm Oil Council (MPOC), 2nd Floor, Wisma Sawit, Lot 6, SS6, Jalan Perbandaran, 47301, Kelana Jaya, Selangor, Malaysia;Faculty of Medicine, University Malaya, 50603, Kuala Lumpur, Malaysia;Malaysian Palm Oil Board (MPOB), 6, Persiaran Institusi, Bandar Baru Bangi, 43000, Kajang, Selangor, Malaysia

关键词: Postprandial plasma lipoproteins;    Vitamin E;    Tocopherols;    Tocotrienols;   

Others  :  825890
DOI  :  10.1186/1475-2891-11-5

 received in 2011-09-09, accepted in 2012-01-17,  发布年份 2012

【 摘 要 】

Background

Tocotrienols (T3) and tocopherols (T), both members of the natural vitamin E family have unique biological functions in humans. T3 are detected in circulating human plasma and lipoproteins, although at concentrations significantly lower than α-tocopherol (α-T). T3, especially α-T3 is known to be neuropotective at nanomolar concentrations and this study evaluated the postprandial fate of T3 and α-T in plasma and lipoproteins.

Methods

Ten healthy volunteers (5 males and 5 females) were administered a single dose of vitamin E [526 mg palm tocotrienol-rich fraction (TRF) or 537 mg α-T] after 7-d pre-conditioning on a T3-free diet. Blood was sampled at baseline (fasted) and 2, 4, 5, 6, 8, and 24 h after supplementation. Concentrations of T and T3 isomers in plasma, triacylglycerol-rich particles (TRP), LDL, and HDL were measured at each postprandial interval.

Results

After TRF supplementation, plasma α-T3 and γ-T3 peaked at 5 h (α-T3: 4.74 ± 1.69 μM; γ-T3: 2.73 ± 1.27 μM). δ-T3 peaked earlier at 4 h (0.53 ± 0.25 μM). In contrast, α-T peaked at 6 h (30.13 ± 2.91 μM) and 8 h (37.80 ± 3.59 μM) following supplementation with TRF and α-T, respectively. α-T was the major vitamin E isomer detected in plasma, TRP, LDL, and HDL even after supplementation with TRF (composed of 70% T3). No T3 were detected during fasted states. T3 are detected postprandially only after TRF supplementation and concentrations were significantly lower than α-T.

Conclusions

Bio-discrimination between vitamin E isomers in humans reduces the rate of T3 absorption and affects their incorporation into lipoproteins. Although low absorption of T3 into circulation may impact some of their physiological functions in humans, T3 have biological functions well below concentration noted in this study.

【 授权许可】

   
2012 Fairus et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Serbinova EA, Kagan V, Han D, Packer L: Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol. Free Radic Biol Med 1991, 10:263-275.
• [2]Suarna C, Hood RL, Dean RT, Stocker R: Comparative antioxidant activity of tocotrienols and other natural lipid soluble antioxidants in homogenous system, and in rat and human lipoproteins. Biochim Biophys Acta 1993, 1166:163-170.
• [3]Theriault A, Jun-Tzu C, Wang Q, Gapor A, Adeli K: Tocotrienol: a review of its therapeutic potential. Clin Biochem 1999, 32:309-319.
• [4]Packer L, Weber SU, Rimbach G: Molecular aspects of α-tocotrienol antioxidant action and cell signaling. J Nutr 2001, 131(Suppl):369-373.
• [5]Sylvester PW, Theriault A: Role of tocotrienols in the preventive of cardiovascular disease and breast cancer. Curr Top Nutraceutical Res 2003, 1:121-136.
• [6]Kerckhofts DAJM, Brouns F, Honstra G, Mensink RP: Effects on the human serum lipoprotein profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 2002, 132:2494-2505.
• [7]Schaffer S, Müller WE, Eckert GP: Tocotrienols: constitutional effects in aging and disease. J Nutr 2005, 135:151-154.
• [8]Sen CK, Khanna S, Roy S: Tocotrienols: vitamin E beyond tocopherols. Life Sciences 2006, 78:2088-2098.
• [9]Mensink RP, van Houwelingen AC, Kromhout D, Honstra G: A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 1999, 69:213-219.
• [10]O'Byrne D, Grundy S, Packer L, Devaraj S, Baldenius K, Hoppe PP, Kramer K, Jialal I, Traber MG: Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 2000, 29:834-845.
• [11]Mustad VA, Smith CA, Ruey PP, Edens NK, DeMichele SJ: Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 2002, 76:1237-1243.
• [12]Radhakrishnan AK, Lee AL, Wong PK, Kaur J, Aung H, Nesaretnam K: Daily supplementation of tocotrienol-rich fraction or α-tocopherol did not induce immunomodulatory changes in healthy human volunteers. Br J Nutr 2009, 101:810-815.
• [13]Hayes KC, Pronczuk A, Liang JS: Difference in the plasma transport and tissue concentration of tocopherols and tocotrienols: observations in humans and hamsters. Proc Soc Exp Biol Med 1993, 202:353-359.
• [14]Wahlqvist ML, Krivokuca-Bogetic Z, Sam Lo C: Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without change in coronary risk factors. Nutr Res 1992, 12(Suppl):181-201.
• [15]Qureshi AA, Bradlow BA, Salser WA, Brace LD: Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J Nutr Biochem 1997, 8:290-298.
• [16]Yap SP, Yuen KH, Wong JW: Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. J Pharm Pharmacol 2001, 53:67-71.
• [17]Yap SP, Yuen KH: Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm 2004, 281:67-78.
• [18]Rasool AHG, Yuen KH, Yusoff K, Wong AR, Rahman ARA: Dose dependent elevation of plasma tocotrienol level and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol 2006, 52:473-478.
• [19]Fairus S, Nor RM, Cheng HM, Sundram K: Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α-tocopherol. Am J Clin Nutr 2006, 84:835-842.
• [20]Khosla P, Patel V, Whinter JM, Khanna S, Rakhkovskaya M, Roy S, Sen CK: Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 2006, 8:1059-1068.
• [21]Rasool AHG, Rahman ARA, Yuen KH, Wong AR: Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E. Arch Pharm Res 2008, 31:;1212-1217.
• [22]Food and Nutrition Board, Institute of Medicine: Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. Washington DC: National Academy Press; 2000.
• [23]Sundram K, Hayes KC, Siru OH: Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am J Clin Nutr 1994, 59:841-846.
• [24]Sundram K, Nor RM: From analysis of tocotrienols in different sample matrixes by HPLC. In Methods in Molecular Biology, Oxidative Stress Biomarkers and Antioxidant Protocols. Volume 186. Edited by Armstrong D. Totowa, New Jersey: Humana Press Inc; 2002::221-232.
• [25]Traber MG: Vitamin E regulatory mechanisms. Annu Rev Nutr 2007, 27:347-362.
• [26]Traber MG, Kayden HJ: Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr 1989, 49:517-526.
• [27]Schwenke DC: Vitamin E to prevent cardiovascular disease: pill or dietary package? Curr Opin Lipidol 2007, 18:467-469.
• [28]Ikeda I, Sasaki E, Sugano M: Lymphatic transport of α-, γ- and δ-tocotrienols and α-tocopherol in rats. Int J Vit Nutr Res 1996, 66:217-221.
• [29]Yap SP, Yuen KH, Lim AB: Influence of route of administration on the absorption and disposition of α-, γ- and δ-tocotrienols in rats. J Pharm Pharmacol 2003, 55:53-58.
• [30]Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K: Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogues. FEBS Letters 1997, 409:105-108.
• [31]Anwar K, Iqbal J, Hussain MM: Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J Lipid Res 2007, 48:2028-2038.
• [32]Lodge JK, Ridllington J, Leonard S, Vaule H, Traber MG: α- and γ-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 2001, 36:43-48.
• [33]Traber MG, Burton GW, Hughes L, Ingold KU, Hidaka H, Malloy M, Kane J, Hyams J, Kayden HJ: Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J Lipid Res 1992, 33:1171-1182.
• [34]Kayden HJ, Traber MG: Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 1993, 34:343-358.
• [35]Kiyose C, Muramatsu R, Kameyama Y, Ueda T, Igarashi O: Biodiscrimination of α-tocopherol stereoisomers in humans after oral administration. Am J Clin Nutr 1997, 65:785-789.
• [36]Jeanes YM, Hall WL, Ellard S, Lee E, Lodge JK: The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. Br J Nutr 2004, 92:575-579.
• [37]Abuasal A, Sylvester PW, Kaddoumi A: Intestinal absorption of γ-tocotrienol is mediated by Niemann-Pick C1-Like 1: in situ rat intestinal perfusion studies. Drug Metab Dipos 2010, 38:939-945.
• [38]Abe C, Uchida T, Ohta M, Ichikawa T, Yamashita K, Ikeda S: Cytochrome P450-dependent metabolism of vitamin E isoforms is a critical determinant of their tissue concentration in rats. Lipids 2007, 42:637-645.
• [39]Traber MG, Rader D, Acuff RV, Ramakrishnan R, Brewer HB, Kayden HJ: Vitamin E dose-response studies in humans with use of deuterated RRR-α-tocopherol. Am J Clin Nutr 1998, 68:847-853.
• [40]Meydani M, Cohn JS, Macauley JB, McNamara JR, Blumberg JB, Schaefer EJ: Postprandial changes in the plasma concentration of α- and γ-tocopherol in human subjects fed a fat-rich meal supplemented with fat-soluble vitamins. J Nutr 1989, 119:1252-1258.
• [41]Borel P, Mekki N, Boirie Y, Partier A, Grolier P, Alexandre-Gouabau MC, Beaufrere B, Armand M, Lairon D, Azais-Braesco V: Postprandial chylomicron and plasma vitamin E responses in healthy older subjects compared with younger ones. Eur J Clin Invest 1997, 27:812-821.
• [42]Baliarsingh S, Beg ZH, Ahmad J: The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005, 182:367-374.
• [43]Qureshi AA, Sami SA, Salser WA: Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002, 161:199-207.
• [44]Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC, Wright JJK, Gapor A, Elson CE: Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995, 30:1171-1177.
• [45]Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA: Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 2006, 41:453-461.
• [46]Sen CK, Rink C, Khanna S: Palm oil derived natural vitamin E α-tocotrienol in brain disease and health. J Am Coll Nutr 2010, 29:314S-323S.